The FDA must continue to pressure Chinese authorities to test what is on the market and remove any substandard products found.

Here is another good news/bad news column about the 112th Congress.

Many aid groups who purchase generic drugs for developing countries do not require evidence of bioequivalence.

The 1984 Hatch-Waxman Act created a streamlined path for generic drugs to reach the market after pioneer drug patents expire. The result has been the most vigorous and competitive generic drug market in the world, but the Hatch-Waxman Act does not apply to most biologics. Isolated from a variety of...

With fakes of the cancer drug Avastin popping up in U.S. clinics in the past few months, patients are naturally worried about whether their medicines are safe.  Considering eighty percent of the ingredients in U.S. medicines come from overseas – mostly from China and India because their products are generally...

Until government price controls are lifted, the makers of generics will be unable to cover their production costs.

New data show that health spending over the past several years has been normalizing toward the rate of general inflation, rather than growing higher and higher, as had been the case almost continuously since the 1970s.